Frank Reynolds, of InVivo Therapeutics (NVIV), says the company is on the verge of unprecedented technology for the treatment of the spinal cord.
Browsing: Uncategorized
In our June Research Report, OneMedResearch explores the potential impact of the JOBS Act on the life sciences sector. This month we have also initiated coverage on Opexa Therapeutics and OncoSec Medical, two companies with disruptive technology and the potential for significant returns. In addition, in this issue we provide monthly company updates. We hope you will find this research report very valuable and we appreciate your feedback, insights and questions. You can reply to this email to get in touch with us. Below is a list of companies covered in this issue. OncoSec Medical. This San Diego-based company has…
Zymeworks Inc. is a privately held biotechnology company committed to developing best-in-class protein therapeutics for the treatment of cancer.
According to the American Cancer Society, prostate cancer is the most common type of cancer found in American men, other than skin cancer.
OncoSec Medical is a biopharmaceutical company developing advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers and metastatic disease.
New “rinse and spit” screen for oral cancer could reduce disfigurement and save lives. Vigilant Biosciences, Inc., recently announced the appointment of David Barshis as Chief Executive Officer.
Immunotherapy is the new black when it comes to treating Cancer, raising hope in conquering this age old illness.
This week, we respond to a recent Wall Street Journal article documenting immunotherapy as a new treatment for Cancer. We tell you what companies they missed. OneMedRadio brings you management interviews with Synthetic Biologics, Pluristem, Nanoviricides, and Biovest. We also interviewed Gerry DiFiore, partner at Reed Smith, sponsor of our recent OneMedForum NY 2012 kick off reception in New York City. Gearing up for our third annual trans-Atlantic conference in New York, we have many new interesting companies slated to present. Stay tuned for feature articles highlighting these disruptive technologies. And don’t forget to register to be present July 12th…